{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:24:48Z","timestamp":1765758288561},"reference-count":23,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Health Policy Research Programs","award":["039\/0031"],"award-info":[{"award-number":["039\/0031"]}]},{"name":"Medical Research Council"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.069","type":"journal-article","created":{"date-parts":[[2011,8,29]],"date-time":"2011-08-29T14:09:24Z","timestamp":1314626964000},"page":"7878-7882","source":"Crossref","is-referenced-by-count":43,"title":["Guillain\u2013Barr\u00e9 syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: Self-controlled case series"],"prefix":"10.1016","volume":"29","author":[{"given":"Nick","family":"Andrews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.069_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain\u2013Barr\u00e9 syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0010","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/pmj.76.902.774","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"76","author":"Seneviratne","year":"2000","journal-title":"Post Grad Med J"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association between Guillain\u2013Barr\u00e9 syndrome and influenza vaccine and influenza-like illness using the UK General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0025","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barr\u00e9 syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0030","unstructured":"The H1N1 swine flu vaccination programme 2009\u20132010 Chief Medical Officer Letter. Department of Health 15 October 2009. Available at http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Lettersandcirculars\/Dearcolleagueletters\/DH_107169 [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0035","unstructured":"A (H1N1) swine flu influenza: phase two of the vaccination programme; children over 6 months and under 5 years Chief Medical Officer Letter. Department of Health, 8 December 2009. Available at http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Lettersandcirculars\/Dearcolleagueletters\/DH_109826 [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0040","unstructured":"MHRA Swine flu pandemic vaccines and antivirals: safety review Drug Safety Update \u2013 Pandemic vaccines and antivirals: safety review October 2010. Available at http:\/\/www.mhra.gov.uk\/Safetyinformation\/DrugSafetyUpdate\/CON096812 [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0050","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0055","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0060","unstructured":"Association of British Neurologists\u2019 British Neurological Surveillance Unit (BNSU). Available at http:\/\/www.theabn.org\/AboutTheABN\/BNSU.aspx [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0065","unstructured":"Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, Miller E. Guillain\u2013Barr\u00e9 syndrome and pandemic H1N1 (swine) influenza vaccination in UK children. The Lancet; in press."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0070","unstructured":"British Society for Clinical Neurophysiology. Available at http:\/\/www.bscn.org.uk [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0075","unstructured":"Guillain\u2013Barr\u00e9 syndrome Support Group. Available at http:\/\/www.gbs.org.uk [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0080","unstructured":"Hospital Episode Statistics. The Health and Social Care Information Centre. Available at http:\/\/www.hesonline.org.uk [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/biostatistics\/kxn013","article-title":"Case series analysis for censored, perturbed, or curtailed post-event exposures","volume":"10","author":"Farrington","year":"2009","journal-title":"Biostatistics"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0095","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3201\/eid1609.091837","article-title":"Hospital discharge data for Guillain\u2013Barr\u00e9 syndrome and influenza A (H1N1) vaccine adverse events","volume":"16","author":"Jones","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.069_bib0100","unstructured":"Vaccine adverse event, safety and communication consortium. Available at http:\/\/vaesco.net\/vaesco.html [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0105","unstructured":"Black S. Global: International Evaluation of the Risk of GBS following Pandemic Influenza Vaccine: April 2011. IABS conference on post-licensure evaluation of vaccine safety: current status and future directions. A http:\/\/www.iabs.org\/index.php\/docs\/cat_view\/36-events-brochures-and-programs\/56-post-licensure-evaluation-barcelona-2011 [last accessed 30\/06\/2011]."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0110","unstructured":"Centers for Disease Control and Prevention (CDC). Preliminary results: surveillance for Guillain\u2013Barr\u00e9 syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine \u2013 United States, 2009\u20132010. MMWR Morb Mortal Wkly Rep 2010;59:657\u201361."},{"key":"10.1016\/j.vaccine.2011.08.069_bib0115","doi-asserted-by":"crossref","unstructured":"Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M, et al. Guillain\u2013Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case\u2013control study in Europe. BMJ 2011;343:d3908.","DOI":"10.1136\/bmj.d3908"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:07:05Z","timestamp":1588810025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11013284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":23,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11013284"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}